Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (55 ops.)
Latest filing published 19 Oct 2026 for Travere Therapeutics, Inc., €1.0M.
Filing timeline
BuySaleEric M. Dube
Insider track record
Disclosed buys
0
Disclosed sells
55
Signal history
Eric M. Dube: trading record in brief
Eric M. Dube sold EUR 39,096,432 of Travere Therapeutics, Inc. stock over 29 sales, with a median of EUR 200,773. The three largest follow one another within weeks in 2026: EUR 6,049,976 on October 15, EUR 5,729,815 on September 17 and EUR 5,468,374 on September 16. No purchase.
Eric M. Dube is listed as CHIEF EXECUTIVE OFFICER of this US company on Nasdaq. The 52 filings, published between January 8, 2019 and October 19, 2026, also include 13 share grants and 10 option exercises.
The year 2026 holds half of the record: 26 filings, against 1 to 7 a year from 2019 to 2025. 27 filings fall in the last twelve months, 16 of them sales, which is more than half of all the sales in the record. The earlier years are comparatively quiet.
The median delay before publication is 2 days. Within 30 days of colleagues at Travere Therapeutics, Inc., Dube has 29, 27 and 26 own market trades, in that order. All of them in the same direction. Names in order: Elizabeth E. Reed, William E. Rote and Peter Heerma.
Companies and markets linked to Eric M. Dube
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations83 total
43,735 shares@ US$26.880.026% mcap2.0% of flowCommon StockSEC:0001763494-26-000008:0
200,000 shares@ US$8.930.039% mcap3.0% of flowCommon StockSEC:0001763494-26-000008:1
128,065 shares@ US$52.96720.15% mcap11.5% of flowCommon StockSEC:0001763494-26-000008:2
37,270 shares@ US$54.19970.044% mcap3.4% of flowCommon StockSEC:0001763494-26-000008:3
78,400 shares@ US$55.01790.094% mcap7.3% of flowCommon StockSEC:0001763494-26-000008:4
6,802 shares@ US$64.95080.0094% mcap0.7% of flowCommon StockSEC:0001763494-26-000007:10
99,716 shares@ US$63.25930.13% mcap10.4% of flowCommon StockSEC:0001763494-26-000007:6
95,666 shares@ US$23.340.047% mcap3.7% of flowCommon StockSEC:0001763494-26-000007:0
63,498 shares@ US$61.99450.083% mcap6.5% of flowCommon StockSEC:0001763494-26-000007:1
28,796 shares@ US$62.65530.038% mcap3.0% of flowCommon StockSEC:0001763494-26-000007:2
3,102 shares@ US$63.64340.0042% mcap0.3% of flowCommon StockSEC:0001763494-26-000007:3
270 shares@ US$65.310.0004% mcap0.0% of flowCommon StockSEC:0001763494-26-000007:4
195,841 shares@ US$23.340.096% mcap7.5% of flowCommon StockSEC:0001763494-26-000007:5
96,125 shares@ US$63.63890.13% mcap10.1% of flowCommon StockSEC:0001763494-26-000007:7
108,493 shares@ US$23.340.054% mcap4.2% of flowCommon StockSEC:0001763494-26-000007:8
101,691 shares@ US$64.58660.14% mcap10.9% of flowCommon StockSEC:0001763494-26-000007:9
64,000 shares0Common StockSEC:0001763494-26-000005:0
7,165 shares@ US$41.750.0054% mcap0.7% of flowCommon StockSEC:0001763494-26-000005:2
20 shares@ US$42.660.0000% mcap0.0% of flowCommon StockSEC:0001763494-26-000005:3
56,815 shares@ US$41.010.042% mcap5.2% of flowCommon StockSEC:0001763494-26-000005:1
25,098 shares@ US$31.461.8% of flowCommon StockSEC:0001763494-26-000004:2
60,000 shares@ US$15.462.1% of flowCommon StockSEC:0001763494-26-000004:0
34,902 shares@ US$30.552.4% of flowCommon StockSEC:0001763494-26-000004:1
60,000 shares@ US$30.102.3% of flowCommon StockSEC:0001763494-26-000003:1
60,000 shares@ US$15.462.1% of flowCommon StockSEC:0001763494-26-000003:0
25 of 83 declarations
